Schedule 13G ownership disclosure

IONIS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 462222100

Event date: 2024-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
14,168,116
Percent of class
9.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001897612-24-001867
Form type
SC 13G
Filer
IONIS PHARMACEUTICALS INC
CIK
CIK 874015
Filed
Nov 14, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub